de Burgos FG - Search Results

1

Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure.

Taléns-Visconti R, Rivera Otero M, Sancho-Tello MJ, de Burgos FG, Martínez-Dolz L, Sevilla B, Climent V, Cortés R, Salvador A, Sogorb F, Miro V, Valero R, Perez-Boscá JL, Bertomeu V, Portolés M, Payá R. Taléns-Visconti R, et al. Among authors: de burgos fg. Eur J Echocardiogr. 2006 Jan;7(1):45-52. doi: 10.1016/j.euje.2005.04.014. Epub 2005 Jun 4. Eur J Echocardiogr. 2006. PMID: 15939671

2

Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.

Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V. Cortés R, et al. Among authors: de burgos fg. Am J Hypertens. 2008 Jul;21(7):820-5. doi: 10.1038/ajh.2008.173. Epub 2008 Apr 24. Am J Hypertens. 2008. PMID: 18443568

3

Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology.

Rivera M, Cortés R, Salvador A, Bertomeu V, de Burgos FG, Payá R, Portolés M, Taléns-Visconti R, Martinez-Dolz L, Valero R, Sevilla B, Climent V. Rivera M, et al. Among authors: de burgos fg. Eur J Heart Fail. 2005 Dec;7(7):1168-70. doi: 10.1016/j.ejheart.2005.04.003. Epub 2005 Aug 5. Eur J Heart Fail. 2005. PMID: 16084758 Free article.

4

Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study.

Cortés R, Rivera M, Salvador A, Bertomeu V, de Burgos FG, Roselló-Lletí E, Portolés M, Payá R, Martínez-Dolz L, Climent V. Cortés R, et al. Among authors: de burgos fg. Heart. 2007 Aug;93(8):957-62. doi: 10.1136/hrt.2006.096891. Epub 2007 May 8. Heart. 2007. PMID: 17488774 Free PMC article.

5

Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension.

Roselló-Lletí E, de Burgos FG, Morillas P, Cortés R, Martínez-Dolz L, Almenar L, Grigorian L, Orosa P, Portolés M, Bertomeu V, Rivera M. Roselló-Lletí E, et al. Among authors: de burgos fg. Am J Hypertens. 2012 Feb;25(2):236-42. doi: 10.1038/ajh.2011.202. Epub 2011 Nov 3. Am J Hypertens. 2012. PMID: 22052073

6

Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation.

Marín F, Roldán V, Monmeneu JV, Bodí V, Fernández C, de Burgos FG, Marco P, Sogorb F. Marín F, et al. Among authors: de burgos fg. Am J Cardiol. 1999 Oct 1;84(7):862-4, A9. doi: 10.1016/s0002-9149(99)00453-1. Am J Cardiol. 1999. PMID: 10513790

7

Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.

Jordán A, Roldán V, García M, Monmeneu J, de Burgos FG, Lip GY, Marín F. Jordán A, et al. Among authors: de burgos fg. J Intern Med. 2007 Sep;262(3):385-92. doi: 10.1111/j.1365-2796.2007.01823.x. J Intern Med. 2007. PMID: 17697160 Free article.

8

Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns.

Bueno H, Sinnaeve P, Annemans L, Danchin N, Licour M, Medina J, Pocock S, Sánchez-Covisa J, Storey RF, Jukema JW, Zeymer U, Van de Werf F; EPICOR Investigators. Bueno H, et al. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):3-12. doi: 10.1177/2048872614565912. Epub 2015 Jan 5. Eur Heart J Acute Cardiovasc Care. 2016. PMID: 25561688

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page